Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-09

Clinical Trial Update: Ross River Virus (RRV) Vaccine Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a Ross River virus vaccine for prophylaxis of infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ross River virus vaccine

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Prophylaxis of Ross River Virus Infection | Phase 3 | Status: COMPLETED